Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Yoshimi, A; Mohamed, M; Bierings, M; Urban, C; Korthof, E; Zecca, M; Sykora, KW; Duffner, U; Trebo, M; Matthes-Martin, S; Sedlacek, P; Klingebiel, T; Lang, P; Führer, M; Claviez, A; Wössmann, W; Pession, A; Arvidson, J; O'Marcaigh, AS; van den Heuvel-Eibrink, MM; Starı, J; Hasle, H; Nöllke, P; Locatelli, F; Niemeyer, CM.
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Leukemia. 2007; 21(3):556-560
Doi: 10.1038/sj.leu.2404537
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
-
Busulfan - administration & dosage
-
Child -
-
Child, Preschool -
-
Combined Modality Therapy -
-
Female -
-
Hematopoietic Stem Cell Transplantation - mortality
-
Humans -
-
Infant -
-
Leukemia, Myelomonocytic, Acute - drug therapy
-
Leukemia, Myelomonocytic, Chronic -
-
Male -
-
Postoperative Complications - mortality
-
Recurrence -
-
Remission Induction -
-
Reoperation -
-
Salvage Therapy -
-
Splenectomy -
-
Transplantation Conditioning - adverse effects
-
Transplantation, Homologous - statistics & numerical data
-
Treatment Outcome -
-
Whole-Body Irradiation - adverse effects